Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.
Researchers have identified two proteins on the surface of neurons that may help drive the spread of Parkinson’s disease in ...
A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...
“In recent years there has been a growing recognition of the links between Parkinson’s disease – a brain disorder – and gut health. Here we have strengthened that evidence and shown that microbes in ...
2d
Using the body's own sounds to diagnose Alzheimer's and Parkinson's before the first symptoms appear
Long before the telltale signs of Parkinson's disease appear, including tremors and muscle stiffness, there are other, more ...
The deal gives Cellular Intelligence control of a clinical-stage therapy designed to restore the dopamine-producing nerve ...
GLP-1 RA use is associated with a lower risk of developing Parkinson disease compared with sulfonylurea use in a large cohort study.
EDITOR’S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. The “Shaking Palsy.” Those ...
A large international study suggests gut microbiome changes may help identify the risk for Parkinson’s disease, including in ...
The ARISE trial enrolled 341 patients across the United States, Europe, United Kingdom, and Australia, and is assessing ...
Around 200 people gathered Saturday morning at The Pointe at Barclay for the Parkinson’s Beat It 5K and 1 Mile event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results